Fundz

Gradalis

Dallas, Texas, United States · Biotechnology, Health Care, Therapeutics

Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 registration trial in patients with ovarian cancer. The company’s proprietary bi-shRNA therapy platform, which has been proven in its clinical studies, can be utilized to silence a broad range of genes and is applicable to multiple cancer types.

Key facts

Headquarters
Dallas, Texas, United States
Employees
25
Industries
Biotechnology, Health Care, Therapeutics
Status
Private
Website
www.gradalisinc.com
LinkedIn
Company page

Recent activity at Gradalis

Gradalis funding history

DateRoundAmount
Jun 2025Venture$12.7M

Leadership

  • Rebecca (Winship) Lutz, Vice President
  • Ernie Bognar, Chief Operating Officer

Verified email and direct lines for Gradalis’s decision-makers are on Fundz. See plans

Employee benefit plans

Gradalis files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Gradalis in the news

Companies similar to Gradalis

About Gradalis: questions and answers

What does Gradalis do?

Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 registration trial in patients with ovarian cancer. The company’s proprietary bi-shRNA therapy platform, which has been proven in its clinical studies, can be utilized to silence a broad range of genes and is applicable to multiple cancer types.

Where is Gradalis headquartered?

Gradalis is headquartered in Dallas, Texas, United States.

How many employees does Gradalis have?

Gradalis has about 25 employees.

Has Gradalis raised funding?

Yes. Fundz has recorded 1 funding event for Gradalis. The most recent, $12.7M, was in Jun 2025.

Who leads Gradalis?

Rebecca (Winship) Lutz is a Vice President at Gradalis.

What is the latest news on Gradalis?

On Jun 12, 2025, Gradalis

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Gradalis across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.